Objective. -To develop clinical practice guidelines for the identification, evaluation and treatment of chronic neuropathic pain in spinal cord injury patients. Methods and results. -the methodology was developed by the SOFMER (the French Society for Physical Medicine and Rehabilitation) and incorporates both guidelines for clinical practice and an expert consensus meeting. Following the creation of a Steering Committee and a Scientific Committee, twelve relevant questions were developed. Two experts from different medical specialties were assigned to each question. The 
English version

Introduction: the nature of the problem
In spinal cord injury (SCI) patients, pain has a major impact in terms of reduced quality of life, functional impairment and restricted socioprofessional participation. The estimated prevalence is high, at around 60 to 70%. Different types of pain are commonly observed in SCI patients and a taxonomy has been recently proposed by the International Association for the Study of Pain's (IASP) Spinal Cord Injury Pain Task Force [1] . Of these, chronic neuropathic pain poses real problems in terms of identification and therapeutic strategies. The consequences are such that 37% of paraplegics and 23% of tetraplegics with chronic pain would be willing to trade pain relief for a loss of bladder, bowel or sexual function. Moreover, 38% of paraplegics would be ready to trade pain relief for an absence of motor, sexual or visceral recovery [2] . Chronic neuropathic pain is a major factor in socioprofessional exclusion and is a source of distress and depression; its diagnosis and treatment thus represents one of today's major issues in the management of SCI patients. It was in this context and under the impetus of the Association Francophone Internationale des Groupes d'Animation de la Paraplégie (AFIGAP) and the Société Française de Médecine Physique et de Réadaptation (SOF-MER) that four French-language learned societies (the AFIGAP, the SOFMER, the Société Française d'Evaluation et de Traitement de la Douleur (SFETD) and the Société Française de Neurochirurgie (SFNC) decided to organize an expert consensus approach to dealing with chronic neuropathic pain in the SCI patient.
Methodology
The methodology behind this expert consensus was based on that developed by the SOFMER and incorporated both clinical practice guidelines and an expert meeting [3] . The second step consisted of the constitution of a Steering Committee with representatives of the SOFMER and the AFIGAP ( Table 1) .
The Steering Committee's first meeting (at Cochin Hospital in Paris) enabled the formulation of 12 questions (some of which had sub-questions) judged to be relevant and which were inspired by the Agency for Healthcare Research and Quality's (AHRQ) September 2001 report on the ''Management of Chronic Neuropathic Pain following Traumatic Spinal Cord Injury'' [4] . The next step involved the constitution of a Scientific Committee (Table 2) , composed of designated SFETD and SFNC members and all the Steering Committee members. Lastly, the Scientific Committee designated a pair of literature reviewers for each question, whose medical and scientific specialties were chosen according to (i) the nature of the question and (ii) balanced representation of the sponsoring learned societies.
The following 12 questions were chosen: 
Literature selection and analysis
An exhaustive literature search was performed by staff at the University of Nantes Library (Healthcare Section). Three databases were queried: Pubmed, Biological Abstracts and Pascal. The search was limited to publications in English and French. Lastly, the terms ''human'', ''clinical trial'' and ''adult'' were used to focus more precisely on the objective. The initial search covered a period of ten years. The literature search was performed by combining the key words ''spinal cord injury'' and ''pain'' and ''neuropathic'' and ''pain''. Logical combinations of more specific keywords were then necessary: ''deep brain stimulation'', ''transcranial magnetic stimulation'', ''motor cortex stimulation'', ''spinal cord stimulation'', ''DREZotomy'', ''spinal injections'', ''post-traumatic syringomyelia'', ''neuropathic pain'', ''ulnar nerve compression syndrome'', ''carpal tunnel syndrome'', ''complex regional pain syndrome'' and ''spinal cord injury''.
As a result of this initial literature search, 934 abstracts were reviewed by BPV and 451 were subsequently selected (while excluding fundamental research reports). A second literature search based on the AHRQ report (which goes back several decades) yielded 591 references for analysis (286 of which were selected). In all, 737 articles were selected (BPV), sorted according to the question addressed (BPV, MV and TA) and then sent to the pairs of reviewers (either on a CD with listings and links or on paper).
The designated literature was independently examined by each reviewer. The data extracted from each article was graded for the level of proof according to the ANAES criteria [5] .
Harmonisation of the levels of proof and guideline grading
Two one-day meetings were organized and moderated by the Scientific Committee in order to harmonize the levels of proof and grade the guidelines, with a view to producing a set of consensus guidelines for clinical practice. Lastly, questions for evaluating professional practice among French-speaking specialists were developed by each pair of reviewers and then validated by the Scientific Committee.
Presentation of the conclusions and guidelines
The conclusions and guidelines for each question were presented by one expert from each pair of reviewers during the SOFMER conference (Saint Malo, October 2007) on a day dedicated to expert consensus (October 3 rd ). During the meeting, the questions aimed at validating professional practice were put to the 116 physicians present, with electronic voting. Moreover, 50 practitioners replied via the Internet. Ninety-two percent of the respondees (total n = 166) were physical medicine and rehabilitation (PMR) specialists, with anaesthetists, pain specialists and neurosurgeons comprising the remainder. The entire discussion and all comments were noted by the session's secretary.
Elaboration of the guidelines with respect to professional practice and levels of proof in the literature
The guidelines published here result from summary of this exhaustive literature review and the analysis of professional practice. Prior to publication, the guidelines were reviewed by a multidisciplinary review committee (Table 3) composed of representative paramedical staff (an occupational therapist, a physiotherapist and a state registered nurse), a social worker, neurosurgeons, PMR specialists, a general practitioner and a patient representative appointed by the Association des Paralysés de France.
Conclusion and acknowledgements
This literature review notably underlined the lack of grade 1 studies in the field of non-pharmacological treatment of chronic neuropathic pain in the SCI patient. It is essential to perform rigorous, well-designed prospective studies in this area in the future.
After this lengthy work, we particularly wish to thank the reviewers & authors, the SOFMER (for its financial support for the AFIGAP) and Bénédicte Clément from the Centre Propara (for producing all the translations).
Version française
Introduction : les données du problème
La douleur chez le blessé médullaire a un impact majeur en terme de retentissement sur la qualité de vie, de limitation fonctionnelle et de restriction de participation. Sa prévalence est élevée, estimée autour de 60-70%. Différents types de douleurs sont communément observées chez ces patients, et 
Méthodologie
La méthodologie de cette conférence d'experts repose sur la méthode Sofmer, méthode mixte entre les recommandations de pratique clinique et la conférence d'experts [3] . [4] . L'étape suivante a été la constitution d'un comité scientifique, composé de membres désignés de la SFETD et de la SFNC associés à l'ensemble des membres du comité de pilotage (Tableau 2). Enfin, la désignation de binômes de lecteurs pour chaque question, respectant l'équilibre des disciplines en fonction des questions et celui de l'appartenance aux sociétés promotrices, a été effectuée par le comité scientifique.
Les 12 questions retenues étaient les suivantes :
Q1 : Comment évaluer la douleur neuropathique chronique du blessé médullaire ? Identification, classification, évaluation, à l'exclusion du bilan paraclinique Q2 : Quel bilan paraclinique, pour quelle rentabilité diagnostique dans les douleurs neuropathiques du blessé médullaire ? Q3 : Quels sont les facteurs de risque de survenue et de chronicité de la douleur neuropathique du blessé médullaire ? Q4 : Quelle est l'efficacité des traitements médicamenteux par voie générale ? Q5 : Quelle est l'efficacité des thérapeutiques locorégionales ? Q6 : Quelle est l'efficacité des thérapeutiques physiques ? Q7 : Quelle est l'efficacité des prise en charges psychocomportementales ? Q8 : Quelle est l'efficacité de la prise en charge sociale et environnementale ? Q9: Quelle est l'efficacité des stimulations médullaires ? La lecture de la littérature a été effectuée de façon indépendante au sein de chaque binôme. L'extraction des données de chaque article a fait l'objet d'une attribution de niveaux de preuve selon les critère de l'Anaes [5] .
Harmonisations des niveaux de preuve et grade de recommandations
Deux réunions d'une journée entière chacune ont été organisées pour permettre sous le contrôle et la modération du comité scientifique, l'harmonisation des niveaux de preuve, des grades de recommandations afin d'aboutir à des recommandations consensuelles de pratique clinique. Enfin, l'élaboration de questions, visant a évaluer les pratiques professionnelles des praticiens francophones, a été effectuée par chaque binôme référent et validé par le comité scientifique.
Présentation des conclusions et recommandations
Les 
Conclusion et remerciements
Cette revue de la littérature souligne notamment dans le domaine du traitement non pharmacologique de ces douleurs neuropathiques chroniques du blessé médullaire l'insuffisance d'études de niveau de preuve 1, imposant dans l'avenir des études prospectives bien menées et à la méthodologie rigoureuse.
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